IRCT2014012210826N6已完成2 期
Effect of Chromium Picolinate supplementation on weight, fat mass and Leptin serum in obese and overweight peopel
Shahid Sadoughi University of Medical Science,International branch0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •Body mass index (BMI) over 25 Kg / m2; men and women aged 20 to 50 years old; without diabetes, CVD; didn't heart surgery; lack of menopause; non smoking status; inactive (based on questionnaires) and willing to participate in study. Exclusion criteria: don't use more than 20% drug that they have; unwillingness to do exercise; specific disease during study; smoking during study; menopause.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Effect of supplementation of chromium in glucose of diabetic patientsC18.452.394.750.149Type 2 Diabetes MellitusRBR-79nxr8niversidade Feral do Rio Grande do Norte
招募中
2 期
The effect of Chromium picolinate in Non-Alcoholic Fatty Liveron-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedIRCT20100123003140N15Tabriz University of Medical Sciences46
已完成
3 期
Prevention of endothelial dysfunction in patients with type 2 diabetesDiabetes mellitusIRCT2017052034038N1Khomein University of Medical Sciences96
已完成
不适用
The effect of Cumin pearl on treatment of metabolic syndromeMetabolic Syndrome.metabolic disorders not specifiedIRCT201701193140N20Vice Chancellor for Research, Tabriz University of Medical Sciences48
招募中
3 期
Effect of the therapeutic effect of chromium supplementation with doses of 400 and 600 micrograms on body mass indexPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20210515051298N1Shahre-kord University of Medical Sciences120